Hirotada G Fujii1, Miho C Emoto1, Yuta Matsuoka2, and Ken-ichi Yamada2
1Sapporo Medical University, Sapporo, Japan, 2Kyushu University, Fukuoka, Japan
Synopsis
EPR imaging has been used to
visualize redox status in oxidative brain diseases, but the role of cerebral
glutathione (GSH) is not clear. In this study, using the mouse model of GSH
depletion with diethylmaleate (DEM), the role of GSH in brain redox status was
examined. The remarkable change in redox status in DEM-treated mouse brain was
visualized with EPR imaging, and in vitro assay showed decrease in the level of
GSH. ME-MRI clearly visualized blood-brain barrier dysfunction in DEM-treated
mice. Results indicate that GSH plays an important role in the maintenance of
both brain redox status and BBB integrity.
Puopose
Under normal physiological
conditions, oxidative damage is prevented by the regulation of reactive oxygen
species by the antioxidant network. Major antioxidants in brain are ascorbic
acid (AsA) and glutathione (GSH), and the levels of these antioxidants change
depending on the disease state. Nitroxides are redox-sensitive compounds and
reduced in vivo in the presence of AsA and GSH. Therefore, electron
paramagnetic resonance (EPR) imaging with nitroxides has been used to visualize
the redox status in oxidative brain diseases (1), but the role of GSH on the
reduction reaction of nitroxides is not clear. In the present study, using the
mouse model of GSH depletion with diethylmaleate (DEM), the role of GSH in the
brain redox status was examined non-invasively by EPR imaging with
3-methoxycarbonyl-PROXYL (MCP). Since GSH has a pivotal role in the maintenance
of membrane integrity, it plays an important role in the proper functioning of
blood-brain barrier (BBB). Therefore, the present study was also planned to see
the effect of GSH depletion using DEM on BBB permeability by EPR imaging and ME-MRI.Methods
Paramagnetic nitroxide
imaging probes: MCP was obtained from
NARD Chemicals, Ltd. (Osaka, Japan). 3-Carboxyl-PROXYL
(COP) was purchased from Sigma-Aldrich Co. (St.Louis, USA). DEM was obtained
from Wako Pure Chemicals (Osaka, Japan). Animals: Male C57BL/6 mice aged 5 to 7 weeks with body weights
of 20–25 g were used. DEM-treatment: Mice were given
single injection of DEM (4mmol/kg), intraperitoneally. EPR images and ME-MRI of
mice were carried out 2 h after DEM-treatment. MRI measurements: MRI of mouse heads was acquired
using an MR mini scanner (MR Technology, Tsukuba, Japan) with a 0.5-T permanent
magnet. ME-MRI was taken after administration of MnCl2 (12.5 mg/kg)
to control and DEM-treated mice. EPR imaging measurements: All EPR images
were acquired using an in-house built 750 MHz CW-EPR imager. Using rapid
magnetic field scan system, the fastest data acquisition time for 3D-EPR images
is about 9 sec in cases of 50 ms field scanning (6 mT field scan) and 181
projections.Results and Discussion
The distribution of a
redox-sensitive nitroxide probe, MCP, in control and DEM-treated mouse heads
was visualized with EPR images. The rate constant of the reduction reaction of
MCP in mice was measured as an index of redox status in vivo. The pixel-based reduction rates of MCP in control and
DEM-treated mouse heads were calculated from a series of temporal
three-dimensional EPR images of mice. The obtained reduction rates at each
pixel in the EPR images were displayed as a “redox map”. The redox map from
control and DEM-tread mouse heads was co-registered to the anatomical image of
mouse heads taken by MRI and was shown in Fig. 1. The co-registered images
obtained from control and DEM-treated mouse clearly show that the remarkable difference in the reduction rates were found
in brain area. Fig. 2A shows that the reduction rate of MCP in DEM-treated mouse
brain was significantly lower than the value in control mice. The levels of
several antioxidants (AsA and GSH) were measured in control and DEM-treated
mouse brains. As shown in Fig.2B, the level of GSH in DEM-treated mouse brain
was significantly lower than in control, although no difference was found in
the level of AsA in both mouse brains. The results in Fig. 1 and 2 strongly
indicate that the redox status in mouse brains is apparently changed by the
level of GSH. Next, the effect of GSH depletion due to DEM treatment on BBB
permeability was examined by MRI with gadolinium (Gd) and manganese (Mn) ions. Administration
of DEM was found to increase the BBB permeability to Mn ions, but not to Gd
ions. ME-MRI of control (-DEM) and DEM-treament mice were shown in Fig. 3. MRI results indicate observed BBB dysfunction was associated with brain
GSH depletion.Conclusion
The remarkable change in redox
status in DEM-treated mouse brain was visualized with EPR imaging. In vitro
assay showed the decreased concentration of GSH, but not AsA, in brain after
DEM treatment. ME-MRI clearly visualized BBB dysfunction in DEM-treated mice.
These results indicate that cerebral GSH plays an important role in the maintenance
of both brain redox status and BBB integrity.Acknowledgements
This work was supported by a
grant from the Japanese Society for the Promotion of Science (24791318).References
1 Emoto CM, Fujii GH, et al. Dynamic changes in the distribution and time course of blood-brain barrier-permeable nitroxides in the mouse head with EPR imaging. Free Radic Biol Med. 2014; 74: 222-228.